Biologics fill finish represent one of the fastest growing segments of the pharmaceutical industry. Over the years, these large molecules have demonstrated promising therapeutic outcomes in the treatment of myriad of chronic and challenging disorders, including autoimmune disorders, infectious diseases, genetic disorders, and oncological disorders. These complex entities, such as antibodies, antibody drug conjugates, cell